The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
l‐Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
Abstract
Summary: In November 1996, a panel of pediatric neurologists met to update the consensus statement issued in 1989 by a panel of neurologists and metabolic experts on L‐carnitine supplementation in childhood epilepsy. The panelists agreed that intravenous L‐carnitine supplementation is clearly indicated for valproate (VPA)‐induced hepatotoxicity, overdose, and other acute metabolic crises associated with carnitine deficiency. Oral supplementation is clearly indicated for the primary plasmalemmal carnitine transporter defect. The panelists concurred that oral L‐carnitine supplementation is strongly suggested for the following groups as well: patients with certain secondary carnitine‐deficiency syndromes, symptomatic VPA‐associated hyperammonemia, multiple risk factors for VPA hepatotoxicity, or renal‐associated syndromes; infants and young children taking VPA; patients with epilepsy using the ketogenic diet who have hypocarnitinemia; patients receiving dialysis; and premature infants who are receiving total parenteral nutrition. The panel recommended an oral L‐carnitine dosage of 100 mg/kg/day, up to a maximum of 2 g/day. Intravenous supplementation for medical emergency situations usually exceeds this recommended dosage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acetaminophen Toxicity in an Urban County Hospital
Schiødt, F. V., Rochling, F. A., Casey, D. L., & Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371602 · Cited by 422
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Perucca, E. (2002) · CNS Drugs · doi:10.2165/00023210-200216100-00004 · Cited by 690
Early‐ and Late‐onset Complications of the Ketogenic Diet for Intractable Epilepsy
Kang, H. C., Chung, D. E., Kim, D. W., & Kim, H. D. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.10004.x · Cited by 390
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
Silva, M. F. B., Aires, C. C. P., Luis, P. B. M., Ruiter, J. P. N., IJlst, L., Duran, M., Wanders, R. J. A., & Tavares de Almeida, I. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0841-x · Cited by 382
Idiosyncratic Adverse Reactions to Antiepileptic Drugs
Zaccara, G., Franciotta, D., & Perucca, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01041.x · Cited by 364
Metadata
- Authors
- De Vivo, D. C., Bohan, T. P., Coulter, D. L., Dreifuss, F. E., Greenwood, R. S., Nordli, D. R., Shields, W. D., Stafstrom, C. E., & Tein, I.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 1998-11
- Volume
- 39
- Issue
- 11
- Pages
- 1216-1225
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1997425654
- Cited by
- 170
- References
- 1
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: l‐Carnitine Supplementation in Childhood Epilepsy: Current Perspectives. https://app.cochat.ai/papers/10.1111/j.1528-1157.1998.tb01315.x
- The paper
- De Vivo, D. C., Bohan, T. P., Coulter, D. L., Dreifuss, F. E., Greenwood, R. S., Nordli, D. R., Shields, W. D., Stafstrom, C. E., & Tein, I. (1998). l‐Carnitine Supplementation in Childhood Epilepsy: Current Perspectives. Epilepsia. https://doi.org/10.1111/j.1528-1157.1998.tb01315.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.